BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8951785)

  • 1. Interferon treatment in polycythaemia vera.
    Reilly JT; Vellenga E; De Wolff JT
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():143-8. PubMed ID: 8951785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: a study of 17 patients and an analysis of published data.
    Taylor PC; Dolan G; Ng JP; Paul B; Collin R; Reilly JT
    Br J Haematol; 1996 Jan; 92(1):55-9. PubMed ID: 8562411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-interferon for intractable pruritus in polycythaemia vera.
    de Wolf JT; Hendriks DW; Egger RC; Esselink MT; Halie MR; Vellenga E
    Lancet; 1991 Jan; 337(8735):241. PubMed ID: 1670870
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic efficacy of recombinant interferon-alpha in polycythaemia vera.
    Oztürk A; Günay A; Uskent N
    Acta Haematol; 1998; 99(2):89-91. PubMed ID: 9554456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylate.
    Silver RT
    Curr Hematol Rep; 2005 May; 4(3):235-7. PubMed ID: 15865878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
    Rain JD
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update.
    Sacchi S
    Leuk Lymphoma; 1995 Sep; 19(1-2):13-20. PubMed ID: 8574158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa.
    Finelli C; Gugliotta L; Gamberi B; Vianelli N; Visani G; Tura S
    Am J Hematol; 1993 Aug; 43(4):316-8. PubMed ID: 8372816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
    Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
    Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT; Peterson P; Geller SA; Rappaport H
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal management of polycythaemia vera.
    Spivak JL
    Br J Haematol; 2002 Feb; 116(2):243-54. PubMed ID: 11841424
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera.
    Muller EW; de Wolf JT; Egger R; Wijermans PW; Huijgens PC; Halie MR; Vellenga E
    Br J Haematol; 1995 Feb; 89(2):313-8. PubMed ID: 7873381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera.
    Stasi R; Brunetti M; Bussa S; Venditti A; Del Poeta G; Conforti M; Scimò MT; Cudillo L; Adorno G; Cecconi M; Amadori S; Pagano A
    J Intern Med; 1997 Aug; 242(2):143-7. PubMed ID: 9279291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythaemia vera.
    Foa P; Massaro P; Caldiera S; LaTargia ML; Iurlo A; Clerici C; Fornier M; Bertoni F; Maiolo AT
    Eur J Haematol; 1998 May; 60(5):273-7. PubMed ID: 9654155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pruritus and severe iron deficiency in polycythaemia vera.
    Salem HH; Van der Weyden MB; Young IF; Wiley JS
    Br Med J (Clin Res Ed); 1982 Jul; 285(6335):91-2. PubMed ID: 6805840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of human leukocyte interferon-alpha in the treatment of patients with polycythemia vera.
    Stasi R; Venditti A; Del Poeta G; Conforti M; Brunetti M; Bussa S; Amadori S; Pagano A
    Am J Med Sci; 1998 Apr; 315(4):237-41. PubMed ID: 9537637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycythaemia vera and myelofibrosis.
    Ikkala E; Rapola J; Kotilainen M
    Scand J Haematol; 1967 Dec; 4(6):453-64. PubMed ID: 6082224
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.
    Silver RT
    Curr Hematol Malig Rep; 2007 Feb; 2(1):43-6. PubMed ID: 20425387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies.
    Kreft A; Büche G; Ghalibafian M; Buhr T; Fischer T; Kirkpatrick CJ
    Acta Haematol; 2005; 113(2):137-43. PubMed ID: 15802893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.